Asenapine: Transdermal vs Sublingual?

ASENAPINE:
TRANSDERMAL VS SUBLINGUAL

This post will summarize the key differences between the transdermal and sublingual formulation of asenapine in the following 10 minutes of video discussion.

By Dr. Harvinder Singh

SUMMARY:

FDA approved the transdermal asenapine formulation (SECUADO®) in 2019 and here is our website post from Oct 2019 summarizing this formulation in the following sections:

  1. Indication
  2. Dosing & Administration
  3. Application Sites
  4. Dose Conversion from Oral Asenapine
  5. Contraindications
  6. Laboratory workup.Investigations
  7. Drug Interactions
REFERENCES:
  1. Noven Pharmaceuticals, Inc. Media Press Release
  2. Carrithers, B., & El-Mallakh, R. S. (2020). Transdermal Asenapine in Schizophrenia: A Systematic Review. Patient preference and adherence, 14, 1541–1551. (pubmed)
  3. SECUADO® (asenapine) transdermal system package insert. (PDF)

OUR CONFERENCE IS ONLINE NOW:

Psychiatry Education Forum’s Bipolar Disorder Update 2020:

PSYCHIATRY EDUCATION FORUM'S SECOND ONLINE CME CONFERENCE:
BIPOLAR DISORDER UPDATE 2020

We guarantee that you will be accessing the most updated information for your invested time at a highly affordable cost.

RELEASE DATE: DEC 15, 2020

AVAILABLE FOR ENROLLMENT OPEN 

Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to improve your clinical decision-making. We are enthralled to release our second online CME conference. Once again, we guarantee that you will be accessing the most updated information for your invested time at a highly affordable cost.

Our second conference focuses exclusively on one of the most important aspects of your practice:

Managing Various Aspects of Bipolar Disorder.

CONFERENCE INTRODUCTION VIDEO:

CME ACCREDITATIONS

8.75 AMA PRA Category 1 Credits Available

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and the Psychiatry Education Forum LLC. PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Related Articles